Obinna Chijioke

8PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of diseaseMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 23, 2024
Stem cell memory EBV-specific T cells control EBV tumor growth and persist in vivo.

Darya Palianina, Juliane Mietz, Claudia Stühler

|Feb 02, 2024
Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia.

Florian Märkl, Christoph Schultheiß, Murtaza Ali

|Mar 09, 2023
CD4+ T cells in cancer.

Daniel E Speiser, Obinna Chijioke, Karin Schaeuble

|Jul 29, 2021
IL-10 induces IgG4 production in NOD-scid Il2rγnull mice humanized by engraftment of peripheral blood mononuclear cells.

Lacin Cevhertas, Siyuan Ma, Barbara Stanic

|Jun 25, 2020
EBV renders B cells susceptible to HIV-1 in humanized mice.

Donal McHugh, Renier Myburgh, Nicole Caduff

|Jul 25, 2019
Erratum for Murer et al., "MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo".

Anita Murer, Julia Rühl, Andrea Zbinden

Pageof 2

Frequent Collaborators

6 joint publications

Christian Münz

2 joint publications

Wolfgang Hammerschmidt

2 joint publications

Juliane Mietz

1 joint publications

Riccarda Capaul